Piromelatine
- Generic Name
- Piromelatine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C17H16N2O4
- CAS Number
- 946846-83-9
- Unique Ingredient Identifier
- S3UN2146K9
- Background
Piromelatine has been used in trials studying the treatment of Alzheimer's Disease.
- Associated Conditions
- -
- Associated Therapies
- -
Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)
- First Posted Date
- 2015-11-25
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- Neurim Pharmaceuticals Ltd.
- Target Recruit Count
- 371
- Registration Number
- NCT02615002
- Locations
- 🇺🇸
Biomed Research Institute, Miami, Florida, United States
🇺🇸Advanced Clinical research Network, Miami, Florida, United States
🇺🇸Alliance for Research, Long Beach, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath